首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: A systematic review and meta-analysis of randomized controlled trials
【24h】

Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: A systematic review and meta-analysis of randomized controlled trials

机译:低热量饮食或低热量饮食后抗肥胖药,饮食和运动对维持体重减轻的影响:随机对照试验的系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Weight-loss maintenance remains a major challenge in obesity treatment. Objective: The objective was to evaluate the effects of anti-obesity drugs, diet, or exercise on weight-loss maintenance after an initial very-low-calorie diet (VLCD)/low-calorie diet (LCD) period (<1000 kcal/d). Design: We conducted a systematic review by using MEDLINE, the Cochrane Controlled Trial Register, and EMBASE from January 1981 to February 2013. We included randomized controlled trials that evaluated weight-loss maintenance strategies after a VLCD/LCD period. Two authors performed independent data extraction by using a predefined data template. All pooled analyses were based on random-effects models. Results: Twenty studies with a total of 27 intervention arms and 3017 participants were included with the following treatment categories: anti-obesity drugs (3 arms; n = 658), meal replacements (4 arms; n = 322), high-protein diets (6 arms; n = 865), dietary supplements (6 arms; n = 261), other diets (3 arms; n = 564), and exercise (5 arms; n = 347). During the VLCD/LCD period, the pooled mean weight change was -12.3 kg (median duration: 8 wk; range 3-16 wk). Compared with controls, anti-obesity drugs improved weight-loss maintenance by 3.5 kg [95% CI: 1.5, 5.5 kg; median duration: 18 mo (12-36 mo)], meal replacements by 3.9 kg [95% CI: 2.8, 5.0 kg; median duration: 12 mo (10-26 mo)], and high-protein diets by 1.5 kg [95% CI: 0.8, 2.1 kg; median duration: 5 mo (3-12 mo)]. Exercise [0.8 kg; 95% CI: -1.2, 2.8 kg; median duration: 10 mo (6-12 mo)] and dietary supplements [0.0 kg; 95% CI: -1.4, 1.4 kg; median duration: 3 mo (3-14 mo)] did not significantly improve weight-loss maintenance compared with control. Conclusion: Anti-obesity drugs, meal replacements, and high-protein diets were associated with improved weight-loss maintenance after a VLCD/LCD period, whereas no significant improvements were seen for dietary supplements and exercise.
机译:背景:维持减肥仍然是肥胖症治疗的主要挑战。目的:目的是评估最初的超低热量饮食(VLCD)/低热量饮食(LCD)时期(<1000 kcal /个)后,抗肥胖药,节食或运动对维持体重减轻的影响d)。设计:1981年1月至2013年2月,我们使用MEDLINE,Cochrane对照试验注册簿和EMBASE进行了系统评价。我们纳入了随机对照试验,评估了VLCD / LCD期后的减肥维持策略。两位作者使用预定义的数据模板进行了独立的数据提取。所有汇总分析均基于随机效应模型。结果:二十项研究共包括27个干预组和3017名参与者,包括以下治疗类别:抗肥胖药(3组; n = 658),代餐(4组; n = 322),高蛋白饮食(6臂; n = 865),膳食补充剂(6臂; n = 261),其他饮食(3臂; n = 564)和运动(5臂; n = 347)。在VLCD / LCD期间,合并的平均体重变化为-12.3 kg(中位持续时间:8 wk;范围3-16 wk)。与对照组相比,抗肥胖药可将减肥维持率提高3.5公斤[95%CI:1.5、5.5公斤;中位时间:18个月(12-36个月)],进餐量减少3.9公斤[95%CI:2.8,5.0公斤;中位持续时间:12 mo(10-26 mo)],高蛋白饮食1.5 kg [95%CI:0.8,2.1 kg;中位持续时间:5个月(3到12个月)]。运动[0.8公斤; 95%CI:-1.2,2.8千克;中位持续时间:10 mo(6-12 mo)]和膳食补充剂[0.0 kg; 95%CI:-1.4,1.4千克;中位持续时间:3 mo(3-14 mo)]与对照组相比,并未显着改善减肥效果。结论:在VLCD / LCD时期之后,抗肥胖药,代餐和高蛋白饮食与改善的减肥维持有关,而膳食补充剂和运动没有明显改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号